NVO - Novo Nordisk A/S

Industry: Drug Manufacturers - Other Sector: Healthcare Exchange: NYSE

Thu 19'th Oct 2017

PERIOD 2017-07-20 - 2017-10-19
CHANGE 1.10%
PRICE $50.68
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Novo Nordisk A/S Stock Analysis

Technical stock analysis for Thu 19'th Oct 2017

Buy candidate since 2017-10-13 Gain 6.63%

Novo Nordisk A/S gained 1.10% in the last trading day, rising from $50.13 to $50.68 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 3.56% over the past 2 weeks. Volume fell in the last day by -0.63 million shares, and in total, 2.63 million shares bought and sold for approximately $133.38 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

Novo Nordisk A/S lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.25% during the next 3 months and, with 90% probability hold a price between $57.10 and $62.43 at the end of this period.

Signals

Only positive signals in the chart today. Novo Nordisk A/S holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $49.34 and $48.68. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday October 13, 2017, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

A sell signal from a double top formation was found on Wednesday October 11, 2017 and based on theory for this formation the price should fall by -1.21% to $48.01 within 13 trading days since signal was issued (Monday October 30, 2017).

Relative Strength Index (RSI)

RSI14 is 66 and the stock is currently not being overbought or oversold

Support & Resistance

Novo Nordisk A/S finds support from accumulated volume at $49.06. There is no resistance from accumulated volume above today's level and given the right condition the stock may perform very well during the next couple of days.

Support: $49.06 Price: $50.68

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.52 (1.03%) between high and low. For the last week, the stock has had a daily average volatility of 1.19%.

Our recommended stoploss: $48.99 (-3.33%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy NVO CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add NVO My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL